| 1 |
19646194 | Effects of rosiglitazone and pioglitazone on lipoprotein metabolism in patients with Type 2 diabetes and normal lipids. | 2009 May |
1 |
| 2 |
18413496 | Increased high-density lipoprotein cholesterol predicts the pioglitazone-mediated reduction of carotid intima-media thickness progression in patients with type 2 diabetes mellitus. | 2008 Apr 22 |
1 |
| 3 |
17229249 | Metabolic effects of pioglitazone and rosiglitazone in patients with diabetes and metabolic syndrome treated with metformin. | 2007 Feb |
1 |
| 4 |
16644631 | Improvement of glycemic control, triglycerides, and HDL cholesterol levels with muraglitazar, a dual (alpha/gamma) peroxisome proliferator-activated receptor activator, in patients with type 2 diabetes inadequately controlled with metformin monotherapy: A double-blind, randomized, pioglitazone-comparative study. | 2006 May |
1 |
| 5 |
12809958 | A randomized, double-blind, placebo-controlled, clinical trial of the effects of pioglitazone on glycemic control and dyslipidemia in oral antihyperglycemic medication-naive patients with type 2 diabetes mellitus. | 2003 Apr |
1 |
| 6 |
12466345 | Effects of pioglitazone in nondiabetic patients with arterial hypertension: a double-blind, placebo-controlled study. | 2002 Dec |
1 |